• Are you 18 years of age or older?
  • Have you had ongoing inflammatory back pain for the last 3 months?
  • Is your condition not responding to treatment?

If the answer to these questions is ‘yes’, we would like to hear from you.

We are currently looking for people who may be interested in joining our clinical research studies. The BE MOBILE 1 and BE MOBILE 2 studies are testing an investigational study drug called bimekizumab to see whether it is safe and effective in treating people with nonradiographic axSpA or ankylosing spondylitis (AS). If you qualify for the study, all study-related treatment and care will be provided at no cost to you.

If you would like to learn more about the BE MOBILE 1 and 2 studies, visit www.BEMOBILESTUDY.com or contact us at: